Bank of Montreal’s Abiomed Inc ABMD Stock Holding History

Bank of Montreal’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-170,783	Closed	-$42.9K	–	4500
2022 Q3	$42.9K	Buy	170,783 +118,215	+225%	+$31.9M	0.02%	414
2022 Q2	$13.5K	Buy	52,568 +4,449	+9%	+$1.2M	0.01%	926
2022 Q1	$15.9M	Sell	48,119 -7,148	-13%	-$2.2M	0.01%	934
2021 Q4	$20.2M	Sell	55,267 -27,814	-33%	-$9.4M	0.01%	738
2021 Q3	$27.7M	Sell	83,081 -10,314	-11%	-$3.49M	0.01%	781
2021 Q2	$29.3M	Buy	93,395 +42,331	+83%	+$13M	0.01%	724
2021 Q1	$16.8M	Sell	51,064 -8,511	-14%	-$2.72M	0.01%	753
2020 Q4	$19.3M	Buy	59,575 +15,104	+34%	+$4.18M	0.01%	721
2020 Q3	$11.8M	Buy	44,471 +21,551	+94%	+$6.21M	0.01%	791
2020 Q2	$6.09M	Buy	22,920 +447	+2%	+$89.8K	0.01%	1077
2020 Q1	$3.22M	Sell	22,473 -34,726	-61%	-$5.76M	﹤0.01%	1186
2019 Q4	$9.76M	Buy	57,199 +7,959	+16%	+$1.48M	0.01%	995
2019 Q3	$8.76M	Buy	49,240 +14,792	+43%	+$3.2M	0.01%	933
2019 Q2	$8.97M	Sell	34,448 -4,856	-12%	-$1.29M	0.01%	944
2019 Q1	$11.2M	Sell	39,304 -43,835	-53%	-$14.6M	0.01%	820
2018 Q4	$27M	Buy	83,139 +33,956	+69%	+$11.8M	0.03%	479
2018 Q3	$22.1M	Buy	49,183 +20,997	+74%	+$8.28M	0.02%	614
2018 Q2	$11.5M	Buy	28,186 +7,874	+39%	+$2.85M	0.01%	829
2018 Q1	$5.91M	Buy	20,312 +15,261	+302%	+$3.87M	0.01%	1080
2017 Q4	$947K	Buy	5,051 +2,362	+88%	+$441K	﹤0.01%	1984
2017 Q3	$453K	Buy	2,689 +273	+11%	+$41.3K	﹤0.01%	2320
2017 Q2	$346K	Sell	2,416 -17,486	-88%	-$2.35M	﹤0.01%	2420
2017 Q1	$2.49M	Buy	19,902 +6,520	+49%	+$756K	﹤0.01%	1407
2016 Q4	$1.5M	Sell	13,382 -40,655	-75%	-$4.71M	﹤0.01%	1715
2016 Q3	$6.95M	Sell	54,037 -23,358	-30%	-$2.8M	0.01%	967
2016 Q2	$8.46M	Sell	77,395 -58,138	-43%	-$5.78M	0.01%	886
2016 Q1	$12.8M	Sell	135,533 -33,436	-20%	-$2.82M	0.01%	640
2015 Q4	$15.3M	Buy	168,969 +8,120	+5%	+$689K	0.02%	583
2015 Q3	$14.9M	Sell	160,849 -108,620	-40%	-$9.57M	0.02%	552
2015 Q2	$17.7M	Sell	269,469 -16,047	-6%	-$1.07M	0.02%	564
2015 Q1	$20.4M	Sell	285,516 -114,009	-29%	-$6.19M	0.02%	498
2014 Q4	$15.2M	Sell	399,525 -113,875	-22%	-$3.59M	0.02%	594
2014 Q3	$12.7M	Sell	513,400 -24,740	-5%	-$627K	0.01%	701
2014 Q2	$13.5M	Buy	538,140 +53,138	+11%	+$1.24M	0.02%	669
2014 Q1	$12.6M	Buy	485,002 +6,835	+1%	+$189K	0.02%	571
2013 Q4	$12.8M	Sell	478,167 -17,924	-4%	-$443K	0.02%	513
2013 Q3	$9.46M	Buy	496,091 +221,233	+80%	+$5.06M	0.01%	536
2013 Q2	$5.93M	Buy	+274,858	New	+$5.52M	0.01%	676

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's ABMD Position: Q4 2022 in Review

Bank of Montreal sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 170,783 shares — an estimated $42.9K sold.

Bank of Montreal first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $29.3M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Bank of Montreal reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Bank of Montreal sold 170,783 Abiomed Inc shares in Q4 2022, an estimated $42.9K.
Bank of Montreal first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Bank of Montreal's Abiomed Inc position peaked at $29.3M in Q2 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.